Lok Sabha Question No. 284 (STARRED), answered on 2019-07-12
Subject: Parameters of Pathological Tests
Ministry: HEALTH AND FAMILY WELFARE
Asked by: P.P. Chaudhary, Ravi Kishan Shukla

## GOVERNMENT OF INDIA MINISTRY OF HEALTH AND FAMILY WELFARE DEPARTMENT OF HEALTH AND FAMILY WELFARE

## LOK SABHA STARRED QUESTION NO. 284 TO BE ANSWERED ON THE 12 TH JULY , 2019 PARAMETERS OF PATHOL OGICAL TESTS

## †*284. SHRI P.P. CHAUDHARY: SHRI RAVI KISHAN:

Will  the  Minister  of  HEALTH  AND  FAMILY  WELFARE  be  pleased  to state:

- (a) whether the Government has fixed parameters regarding results of the va pathological tests/investigations under medical services;
- (b) if so, the details thereof;
- (c)  wheth er  the  Government  is  aware  that  some  pharmaceutical  companies  in collusion with doctors are selling medicines by terming the parameters fi wrong;
- (d) if so, the details thereof and the action taken/being taken by the Gov against  such companies  and  doctors  along  with  the  number  of  companies  and doctors against whom action has been taken during each of the last three State - wise; and
- (e) whether the Government proposes to fix the standard parameters for va diagnostic investi ga ons and disseminate the same in public interest and if so details therefor?

## ANSWER

## THE MINISTER OF HEALTH AND FAMILY WELFARE (DR. HARSH VARDHAN)

- (a) to ( e):  A statement is laid on the Table of the House

## STATEMENT REFERRED TO IN REPLY TO LOK SABHA STARRED QUESTION NO. 284* FOR 12 TH JULY , 2019

(a)&(b) The p arameters regarding results of the various pathologica tests/investigation under medical services are defined in internationally accepted medical text books/ reference books .They are usually defined based on various scientific  researches  by  subject  specific  international  professional  asso The  parameters/  reference  range  of  lab  investigation  also  depend  upon procedure of conducting the test in some instances. Acco rdingly, the parameters/ reference  range  of  the  results  may  vary  from  lab  to  lab  depending  upon procedure followed by them. However, under Clinical Establishments Act, 201 the  Allopathic  Standard  Treatment  Guidelines  have  been  prescribed  by  t Government for 227 common medical conditions under which optimal diagnostic criteria including investigations and treatment have been defined. These pre reference range for some conditions for the purpose of therapeutic interventi

(c) & (d) Department  of  Pharmaceuticals  has  received  some  complaints  of unethical  marketing  practices  by  pharmaceutical  companies.  As  informed  b Department  of  Pharmaceuticals,  the  complaints  received  are  forwarded concerned  Pharma  Associations  for  necessary  acti on  as  per  the  provisions  of Uniform Code for Pharmaceutical Marketing Practices (UCPMP) , as prepared by Department  of  Pharmaceuticals.  The  Managing  Director/CEO  of  the  pharma company is ultimately responsible for ensuring the adherence to the code.

Furthe r, Clause 6.8 (Code of Conduct for doctors in their relationship pharmaceutical  and  allied  sector  industry)  of  the  Indian  Medical  Cou (Professional  Conduct,  Etiquette  and  Ethics)  Regulation,  2002  prohibits  do from taking gifts, travel facilit ies, hospitality and cas h or  monetary  grants  from pharmaceutical and allied health sector industry. The said regulation empowe s the Medical  Council  of  India  and  respective  State  Medical  Council s to  award punishment to a doctor against any act in violation of code of Ethics for doctors . Such  complaints  are  referred  by  MCI  to  the  concerned  State  Medical  Counc where the doctors/medical practitioners are registered. The MCI is an Appe Authority.

(e) This information referred to at 'a' and 'b' above is already available in public domain on the website: www.clinicalestablishments.gov.in

- ******